Limes Schlosskliniken AG / DE000A0JDBC7

Limes Schlosskliniken AG: Preliminary group result 2024 (unaudited) forcast 2025

EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Annual Results/Forecast


25-Feb-2025 / 10:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

---

DGAP-Adhoc: Limes Schlosskliniken AG: Preliminary group result 2024 (unaudited) / forecast 2025 Total revenue EUR 38.0m  (p.y. EUR 38.0m)
  Patient days 48,021  + 3 %
  Gross earnings (EBITDA) EUR 7.3m  - 6 %
  Operating result (EBIT) EUR 4.2m  - 17 %
  Earnings before taxes EUR 3.8m  - 18 %
  Clinic start-up costs affect the 2024 result by -430 kEUR
  Forecast 2025: Opening of two new clinics with a total of 180 treatment places in Q2 2025, depending on the final approval of the clinic licenses, which are in preparation, significant increase in revenue for 2025   Cologne, February, 25, 2025:  Against the backdrop of the additional costs caused by the construction of two new clinic locations, the LIMES Group performed solidly in 2024. The LIMES Schlossklinik Mecklenburgische Schweiz, the LIMES Schlossklinik Fürstenhof and the Clinicum Alpinum recorded increases in revenue and earnings with higher patient occupancy. The Paracelsus Recovery Clinic in Zurich performed temporarily weaker, as a result of which we did not quite reach our original projections for 2024. The marketing activities for the PRC Zurich were adjusted. As a result, we had a very good start in 2025. In the current financial year, we will significantly expand the available clinic capacities. The timing of the start of patient occupancy in the new clinics is still subject to uncertainty, as we have only certain influence on the final approval of the clinic concession. Depending on the final granting of the clinic license for the new locations, we expect revenue of around EUR 50 million and EBITDA in the region of EUR 8-9 million in 2025. We assume that the new locations will generate positive profit contributions from 2026.   Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de. Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: [phone], [e-mail], www.limes-schlosskliniken.de

Language:  German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone:   [phone]
Mail:  [e-mail]
Internet:  www.limes-schlosskliniken.de
ISIN:  DE000A0JDBC7
WKN:  AOJDBC
Stock exchange: Düsseldorf Open Market, Primary Market, XETRA

End of the message

End of Inside Information

---

25-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Limes Schlosskliniken AG
	Kaiser-Wilhelm-Ring 26
	50672 Köln
	Germany
ISIN:	DE000A0JDBC7
WKN:	A0JDBC
Listed:	Regulated Unofficial Market in Dusseldorf
EQS News ID:	2091095

End of Announcement	EQS News Service

---

2091095  25-Feb-2025 CET/CEST